AT260640T - Osmotic administration system with pegs retention mechanism - Google Patents

Osmotic administration system with pegs retention mechanism


Publication number
AT260640T AT98963215T AT98963215T AT260640T AT 260640 T AT260640 T AT 260640T AT 98963215 T AT98963215 T AT 98963215T AT 98963215 T AT98963215 T AT 98963215T AT 260640 T AT260640 T AT 260640T
Prior art keywords
retention mechanism
administration system
Prior art date
Application number
Other languages
German (de)
Rupal Ayer
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US6898797P priority Critical
Application filed by Alza Corp filed Critical Alza Corp
Priority to PCT/US1998/026654 priority patent/WO1999033446A1/en
Publication of AT260640T publication Critical patent/AT260640T/en



    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
AT98963215T 1997-12-29 1998-12-15 Osmotic administration system with pegs retention mechanism AT260640T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US6898797P true 1997-12-29 1997-12-29
PCT/US1998/026654 WO1999033446A1 (en) 1997-12-29 1998-12-15 Osmotic delivery system with membrane plug retention mechanism

Publications (1)

Publication Number Publication Date
AT260640T true AT260640T (en) 2004-03-15



Family Applications (1)

Application Number Title Priority Date Filing Date
AT98963215T AT260640T (en) 1997-12-29 1998-12-15 Osmotic administration system with pegs retention mechanism

Country Status (13)

Country Link
US (5) US6270787B1 (en)
EP (1) EP1041968B1 (en)
JP (1) JP4173635B2 (en)
AR (1) AR014194A1 (en)
AT (1) AT260640T (en)
AU (1) AU1828599A (en)
CA (1) CA2316976C (en)
DE (1) DE69822208T2 (en)
ES (1) ES2217613T3 (en)
HK (1) HK1031332A1 (en)
TW (1) TW446552B (en)
WO (1) WO1999033446A1 (en)
ZA (1) ZA9811880B (en)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125870A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
AT260640T (en) * 1997-12-29 2004-03-15 Alza Corp Osmotic administration system with pegs retention mechanism
NZ512671A (en) * 1998-12-31 2003-12-19 Alza Corp Osmotic delivery system having space efficient piston
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
DE60023361T2 (en) * 1999-12-21 2006-04-27 Alza Corp., Mountain View Valve for osmotic devices
US7163688B2 (en) * 2001-06-22 2007-01-16 Alza Corporation Osmotic implant with membrane and membrane retention means
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
EP2339328A3 (en) 2002-12-30 2011-07-13 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of celecoxib
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US8183290B2 (en) * 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
AT550022T (en) 2003-02-28 2012-04-15 Mcneil Ppc Inc Pharmaceutical mixed crystals of celecoxib -nicotinamide
EP1494998A2 (en) * 2002-03-01 2005-01-12 The Regents Of The University Of Michigan Multiple-component solid phases containing at least one active pharmaceutical ingredient
KR20050026402A (en) * 2002-06-17 2005-03-15 알자 코포레이션 Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
IL165383D0 (en) * 2002-06-21 2006-01-15 Transform Pharmaceuticals Inc Pharmaceutical compositions with improved dissolution
AT376854T (en) 2002-06-26 2007-11-15 Alza Corp Minimally compliant volume-efficient piston for osmotic drug delivery systems
US7014636B2 (en) * 2002-11-21 2006-03-21 Alza Corporation Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
RU2342118C2 (en) * 2002-12-19 2008-12-27 Алза Корпорейшн Stable nonaqueous single-phase gels and compositions on their basis for delivery from implanted device
EP1610761A2 (en) * 2003-03-31 2006-01-04 Alza Corporation Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
JP2006521897A (en) 2003-03-31 2006-09-28 アルザ・コーポレーション Osmotic pump comprising a means for dissipating the internal pressure
AT404175T (en) 2003-03-31 2008-08-15 Alza Corp Non-aqueous single phase viscous vehicle-and formulations that use this vehicle-
US20040214893A1 (en) * 2003-04-11 2004-10-28 Matthew Peterson Gabapentin compositions
JP2007502329A (en) 2003-05-23 2007-02-08 トランスフォーム・ファーマシューティカルズ・インコーポレイテッドTransform Pharmaceuticals, Inc. Sertraline composition
US20050089570A1 (en) * 2003-09-26 2005-04-28 Evangeline Cruz Oros push-stick for controlled delivery of active agents
NZ546183A (en) 2003-09-26 2011-04-29 Alza Corp Controlled release formulations exhibiting an ascending rate of release
AU2004275816A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
EP1708684A2 (en) 2003-09-26 2006-10-11 Alza Corporation Drug coating providing high drug loading and methods for providing the same
US8541026B2 (en) * 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
MXPA06002967A (en) 2003-09-30 2006-06-14 Alza Corp Osmotically driven active agent delivery device providing an ascending release profile.
EP1686968A2 (en) * 2003-10-31 2006-08-09 Alza Corporation Osmotic pump with self-retaining, fast-start membrane plug
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
JP2007526792A (en) * 2003-11-06 2007-09-20 アルザ・コーポレーシヨン Modular inhalation rate reduction device for use with an implantable osmotic pump
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
EP1689383B1 (en) 2003-11-19 2012-10-31 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
US20060004037A1 (en) * 2004-03-25 2006-01-05 Transform Pharmaceuticals, Inc. Novel tricyclic compounds and related methods of treatment
US20080022287A1 (en) * 2004-03-31 2008-01-24 Koninklijke Philips Electronics, N.V. Method And System For Transferring Budgets In A Technique For Restrained Budget Use
US20050266087A1 (en) * 2004-05-25 2005-12-01 Gunjan Junnarkar Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
JP5017103B2 (en) * 2004-06-17 2012-09-05 トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド Using that drug co-crystal compositions and related
US8518022B2 (en) 2004-08-27 2013-08-27 Medimetrics Personalized Drug Delivery, Inc. Electronically and remotely controlled pill and system for delivering at least one medicament
US8779175B2 (en) * 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
WO2006073779A1 (en) * 2004-12-30 2006-07-13 Transform Phamaceuticals, Inc. Novel omeprazole forms and related methods
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
JP2008528698A (en) * 2005-02-03 2008-07-31 インターシア セラピューティクス,インコーポレイティド Interferon-containing device that can be embedded
US7959938B2 (en) 2005-03-15 2011-06-14 Intarcia Therapeutics, Inc. Polyoxaester suspending vehicles for use with implantable delivery systems
CA2617336A1 (en) * 2005-06-30 2007-01-11 Alza Corporation Osmotic intraosseous drug delivery system
US20070027105A1 (en) * 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US7931620B2 (en) * 2006-02-01 2011-04-26 Roche Diagnostics International Ag Self-sealing connection for housing shells of an administering device
CN101432032A (en) * 2006-04-28 2009-05-13 皇家飞利浦电子股份有限公司 Osmotic pump with at least one chargeable material
JP5143131B2 (en) * 2006-05-30 2013-02-13 インターシア セラピューティクス,インコーポレイティド Two pieces constituting the osmotic pumping out system internal channel of the flow modulator
EP2359808B1 (en) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotic delivery systems and piston assemblies
US9114133B2 (en) 2006-08-25 2015-08-25 U.S. Dept. Of Veterans Affairs Method of improving diastolic dysfunction
US8617143B2 (en) * 2006-12-07 2013-12-31 The Regents Of The University Of California Therapeutic agent delivery systems and devices
AU2008212816B2 (en) 2007-02-09 2014-08-07 Metabasis Therapeutics, Inc. Novel antagonists of the glucagon receptor
PT2157967E (en) 2007-04-23 2013-04-03 Intarcia Therapeutics Inc Suspension formulations of insulinotropic peptides and uses thereof
CA2694602A1 (en) * 2007-07-27 2009-02-05 Depomed, Inc. Pulsatile gastric retentive dosage forms
CA2695583A1 (en) 2007-08-13 2009-02-19 Metabasis Therapeutics, Inc. Novel activators of glucokinase
JP2011511782A (en) 2008-02-12 2011-04-14 アボット・ラボラトリーズAbbott Laboratories Extended release hydrocodone acetaminophen and its related methods and applications
US8343140B2 (en) * 2008-02-13 2013-01-01 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
CN102292316B (en) 2008-08-13 2015-07-01 症变治疗公司 Glucagon antagonists
AU2009303905B2 (en) * 2008-10-15 2015-01-22 Intarcia Therapeutics, Inc. Highly concentrated drug particles, formulations, suspensions and uses thereof
KR20120006040A (en) 2009-04-07 2012-01-17 코닌클리케 필립스 일렉트로닉스 엔.브이. Modular ingestible drug delivery capsule
WO2011018753A1 (en) * 2009-08-12 2011-02-17 Koninklijke Philips Electronics N.V. Drug delivery device with compressible drug reservoir
RU2547990C2 (en) * 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Fast achievement and/or completion of substantial stable drug delivery
EP2556082B1 (en) 2010-04-08 2017-02-22 Emory University Substituted androst-4-ene diones
SG188317A1 (en) 2010-08-30 2013-04-30 Sinusys Corp Devices for dilating a paranasal sinus opening and for treating sinusitis
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9585930B2 (en) 2011-03-20 2017-03-07 Trustees Of Boston University Therapeutic agent for emphysema and COPD
EP2688559B1 (en) * 2011-03-24 2018-05-09 STOCO 10 GmbH Swallowable medication capsule
ITFI20110114A1 (en) 2011-05-31 2012-12-01 Scuola Superiore Di Studi Universit Arie Di Perfe robotics platform for minimally invasive surgery
WO2013003697A1 (en) 2011-06-30 2013-01-03 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
US20130090633A1 (en) * 2011-10-07 2013-04-11 University Of Southern California Osmotic patch pump
TWI615155B (en) * 2011-11-01 2018-02-21 Bayer Oy Osmotically active vaginal delivery system
US9138569B2 (en) 2012-02-29 2015-09-22 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
US9737364B2 (en) 2012-05-14 2017-08-22 Vanderbilt University Local magnetic actuation of surgical devices
US9296757B2 (en) 2012-05-21 2016-03-29 Bayer Pharma Aktiengesellschaft Substituted benzothienopyrimidines
US9826904B2 (en) 2012-09-14 2017-11-28 Vanderbilt University System and method for detecting tissue surface properties
US20140081169A1 (en) * 2012-09-17 2014-03-20 Vanderbilt University System and method of tetherless insufflation in colon capsule endoscopy
TW201412740A (en) 2012-09-20 2014-04-01 Bayer Pharma AG Substituted pyrrolopyrimidinylamino-benzothiazolones
CN102871982B (en) 2012-10-16 2014-09-10 中国科学院上海药物研究所 Medicine osmotic pump preparation
US9687263B2 (en) 2013-05-30 2017-06-27 SinuSys Corporation Devices and methods for inserting a sinus dilator
CA2924141A1 (en) 2013-08-22 2015-02-26 The General Hospital Corporation Inhibitors of human 12/15-lipoxygenase
EP3154956A4 (en) 2014-06-12 2018-01-17 Ligand Pharmaceuticals, Inc. Glucagon antagonists
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
WO2018075901A1 (en) 2016-10-20 2018-04-26 Peptron, Inc. Methods of delivering a neuroprotective polypeptide to the central nervous system
WO2018165462A1 (en) 2017-03-08 2018-09-13 Intarcia Therapeutics, Inc Apparatus and methods for administration of a nauseogenic compound from a drug delivery device

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732865A (en) 1971-01-13 1973-05-15 Alza Corp Osmotic dispenser
US3995631A (en) 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3929132A (en) * 1973-04-10 1975-12-30 Alza Corp Osmotic dispenser
US3995632A (en) 1973-05-04 1976-12-07 Alza Corporation Osmotic dispenser
US3916889A (en) 1973-09-28 1975-11-04 Sandoz Ag Patient ventilator apparatus
US3888249A (en) * 1973-11-02 1975-06-10 David L Spencer Arterial infusion catheter
US4111202A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4203439A (en) 1976-11-22 1980-05-20 Alza Corporation Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
US4111203A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4243030A (en) 1978-08-18 1981-01-06 Massachusetts Institute Of Technology Implantable programmed microinfusion apparatus
US4373527B1 (en) 1979-04-27 1995-06-27 Univ Johns Hopkins Implantable programmable medication infusion system
US4340054A (en) 1980-12-29 1982-07-20 Alza Corporation Dispenser for delivering fluids and solids
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4552561A (en) 1982-12-23 1985-11-12 Alza Corporation Body mounted pump housing and pump assembly employing the same
US4639244A (en) 1983-05-03 1987-01-27 Nabil I. Rizk Implantable electrophoretic pump for ionic drugs and associated methods
US4865845A (en) 1986-03-21 1989-09-12 Alza Corporation Release rate adjustment of osmotic or diffusional delivery devices
US4874388A (en) 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US5151093A (en) 1990-10-29 1992-09-29 Alza Corporation Osmotically driven syringe with programmable agent delivery
GB9027422D0 (en) 1990-12-18 1991-02-06 Scras Osmotically driven infusion device
US5137727A (en) 1991-06-12 1992-08-11 Alza Corporation Delivery device providing beneficial agent stability
US5223265A (en) 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
US5456679A (en) 1992-02-18 1995-10-10 Alza Corporation Delivery devices with pulsatile effect
US5308348A (en) 1992-02-18 1994-05-03 Alza Corporation Delivery devices with pulsatile effect
CA2193806A1 (en) * 1994-06-22 1995-12-28 Michael Cardamone Controlled release device and method
US5731001A (en) * 1995-06-07 1998-03-24 Magruder; Judy A. Locking couplings for osmotic delivery devices
DK1238658T3 (en) * 1996-02-02 2005-04-04 Alza Corp Understöttet delivery of an active agent using an implantable system
AT260640T (en) * 1997-12-29 2004-03-15 Alza Corp Osmotic administration system with pegs retention mechanism
KR100568917B1 (en) * 1997-12-30 2006-04-07 알자 코포레이션 Beneficial agent delivery system with membrane plug

Also Published As

Publication number Publication date
US6899887B2 (en) 2005-05-31
JP4173635B2 (en) 2008-10-29
US6270787B1 (en) 2001-08-07
DE69822208T2 (en) 2005-04-28
US20010022974A1 (en) 2001-09-20
CA2316976C (en) 2009-02-17
DE69822208D1 (en) 2004-04-08
JP2001526939A (en) 2001-12-25
EP1041968A1 (en) 2000-10-11
ES2217613T3 (en) 2004-11-01
TW446552B (en) 2001-07-21
AU1828599A (en) 1999-07-19
AR014194A1 (en) 2001-02-07
US20050048097A1 (en) 2005-03-03
WO1999033446A1 (en) 1999-07-08
US20010021822A1 (en) 2001-09-13
CA2316976A1 (en) 1999-07-08
US20040243106A1 (en) 2004-12-02
ZA9811880B (en) 1999-06-29
EP1041968B1 (en) 2004-03-03
HK1031332A1 (en) 2004-12-10
US6976981B2 (en) 2005-12-20

Similar Documents

Publication Publication Date Title
DE69434448D1 (en) Polymer-peptide conjugates
DE69836439D1 (en) degradation rates with controlled Polyhydroxyalkanoatzusammensetzungen
DE69316015D1 (en) bupropion tablets with sustained release comprising
DK0798436T3 (en) locking device
DE69732760D1 (en) Intravaginally-rings with einsetzbarem drug-containing core
DE69732830D1 (en) Gastrointestinal drug administration system
DK0739831T3 (en) Transporter
DE69841860D1 (en) angiographic injector
DK0868530T3 (en) The cascade-nucleinsyreamplificeringsreaktion
DE69528583T2 (en) Colon-specific drug release system
DK0906089T3 (en) The buccal delivery system
DK1003783T3 (en) Lipoproteinregulerende medications
DE69605587D1 (en) Quick connection with release mechanism
DK0614653T3 (en) fluid delivery system
DK1060329T3 (en) dosing System
DK0968722T3 (en) Modified Improved BRSV vaccine
DE69826263D1 (en) Sonodynamic therapy with ultraschalsensibilisator
DE69108850D1 (en) Three-way valve.
DE523680T1 (en) Photometric device.
DK0944398T3 (en) Percutaneous administration system
NO964976L (en) Copolymer-1 improvements kopolymerpreparater
FI950950A0 (en) Remote-use game system
DE68901417D1 (en) Pharmaceutical composition.
DK1007115T3 (en) medication delivery
AT303593T (en) Differenzgelelektrophorese with multiple dyes concord

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties